DAX23.910 -0,4%ESt505.338 -0,5%Top 10 Crypto13,68 -3,6%Dow42.270 +0,1%Nas19.114 -0,3%Bitcoin91.229 -2,0%Euro1,1419 +0,6%Öl65,28 +2,2%Gold3.356 +1,9%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 RENK RENK73 HENSOLDT HAG000 NVIDIA 918422 BYD A0M4W9 Siemens Energy ENER6Y Tesla A1CX3T Lufthansa 823212 thyssenkrupp 750000 BASF BASF11 Bayer BAY001 Mercedes-Benz Group (ex Daimler) 710000 Deutsche Bank 514000 Deutsche Telekom 555750 Allianz 840400
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Zollchaos: DAX gibt nach -- Trump will Stahlzölle verdoppeln - EU reagiert -- DHL erhöht Preise für Privat-Pakete -- Infineon, Rheinmetall, RENK, Siemens Energy im Fokus
Top News
BioNTech-Aktie schießt dank Milliarden-Kooperation mit Bristol-Myers zweistellig hoch BioNTech-Aktie schießt dank Milliarden-Kooperation mit Bristol-Myers zweistellig hoch
BionTechs großer Krebsdeal: Milliarden für Hoffnungsträger BNT327 von Bristol Myers! BionTechs großer Krebsdeal: Milliarden für Hoffnungsträger BNT327 von Bristol Myers!
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
FONDSPREMIERE: BIT Capital legt ersten Multi-Asset-Fonds auf

AstraZeneca Aktie

Handeln
Aktien-Sparplan anlegen
126,05 EUR -1,60 EUR -1,25 %
XETRA
106,09 GBP -1,11 GBP -1,04 %
LSE
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.197,30 Mrd. EUR

KGV29,47Div. Rendite2,35%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN886455

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINGB0009895292

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolAZNCF

AstraZeneca Aktien News

DatumMeistgelesen
PR NewswireDanaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine
PR NewswireSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
PR NewswireSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
Wer­bungAstraZeneca-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
PR NewswireSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
PR NewswireIgniteData launches cutting edge data integration platform for clinical trials at Cambridge University Hospitals
PR NewswireLeading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing
PR NewswireFinal Deadline for the AstraZeneca PLC Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - AZN
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireAstraZeneca PLC Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN
PR NewswireShareholders that lost money on AstraZeneca PLC(AZN) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireAstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery
PR NewswireAstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireAstraZeneca PLC (AZN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PR NewswireThe Gross Law Firm Notifies AstraZeneca PLC Investors of a Class Action Lawsuit and Upcoming Deadline - AZN
PR NewswireSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireASTRAZENECA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Ag...
PR NewswireAZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireAZN Investors have Opportunity to Lead AstraZeneca PLC Securities Fraud lawsuit
PR NewswireRosen Law Firm Encourages AstraZeneca PLC Investors to Inquire About Securities Class Action Investigation - AZN
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN
PR NewswireGRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN
PR NewswireSOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
PR NewswireSOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
PR NewswireSOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
PR NewswireSOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
PR NewswireVoydeya approved in Canada as add-on therapy to ravulizumab or eculizumab for adults with the rare disease PNH who have residual hemolytic anemia due to extravascular hemolysis
PR NewswireVoydeya approved in Canada as add-on therapy to ravulizumab or eculizumab for adults with the rare disease PNH who have residual hemolytic anemia due to extravascular hemolysis
PR NewswireI-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
PR NewswireAbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024
PR NewswireAbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
PR NewswireAlexion Canada Raises Awareness for Rare Diseases Through International colourUp4RARE Campaign
PR NewswireAlexion Canada Raises Awareness for Rare Diseases Through International colourUp4RARE Campaign
Wer­bung

AstraZeneca News

AstraZeneca News: auf dieser Seite finden Sie alle AstraZeneca News und Nachrichten zur AstraZeneca Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch AstraZeneca News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um AstraZeneca News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.